Innovation Storytellers

In my conversation with Eric West, Chief Growth Officer at Convertible AI, we explored how synthetic data is reshaping AI strategies and why so many companies are working in silos instead of scaling AI effectively. Eric highlights the power of synthetic data. Data that is created rather than collected from customers is proving to be a game changer in AI adoption. It allows companies to simulate scenarios, improve forecasting, and fill gaps in real-world datasets at an unprecedented speed. But the challenge? Many businesses are unknowingly duplicating efforts across multiple teams, wasting valuable resources and missing opportunities to collaborate. This reminds me of the early days of the Internet when every department within a company was building its own independent website with no connection to the bigger picture. AI adoption is facing a similar challenge. Without coordination, businesses risk slowing down progress instead of accelerating it. The question is, how can organizations align their AI initiatives to maximize impact? Are companies fully leveraging synthetic data to enhance decision-making? I would love to hear your thoughts on this. ?? Listen Now: ?? Website: https://zurl.co/T0zGZ ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa

Autonomous technology has been promised for years, but are we chasing the wrong goal? In my latest conversation with Eric R West, Chief Growth Officer at Convertible AI, we dig into the reality behind automation in the automotive world and the parallels between autonomous driving and artificial general intelligence (AGI). Eric points out that just because something is possible doesn’t mean it holds commercial value. The industry has poured billions into full autonomy, but OEMs are now pivoting away from this as their sole focus. The key? Identifying actual customer use cases where automation enhances safety, security, and efficiency—not just chasing a futuristic ideal. This shift highlights a broader lesson about technology push vs. market pull. While groundbreaking advances can drive innovation, real success comes from aligning with what customers actually need and are willing to pay for. So where do you see automation delivering the most value today? Are we moving toward practical applications of AI, or are we still caught up in the full-autonomy dream? Let me know your thoughts in the comments. ?? Listen Now: ?? Website: https://zurl.co/RQXiD ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa #AGI #AI #innovation #Podcast

?? When the Least Expected Becomes the Most Loved ?? Some of the biggest, most legendary hits? They almost never made it. In my conversation with Amani Roberts on the Innovation Storytellers Show, he shared a fascinating insight—many platinum-status songs were either afterthoughts, added last-minute to an album, or the songs the artists liked the least. And yet, they’re the ones that the public connects with the most. This flips everything we think we know about creativity and innovation on its head. Sometimes, the best ideas aren’t the ones meticulously planned—they’re the risks, the experiments, the unexpected breakthroughs. ?? So, how does innovation actually happen in music? Amani says it starts with taking creative risks. And if you think about it, that applies far beyond music. The biggest successes often come from places we least expect. What’s an idea, project, or creation you almost dismissed—but turned out to be a huge win? Drop your thoughts below! ?? ?? Listen Now: ?? Website: https://zurl.co/zIqrw ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa #Innovation #Podcast #Music

Amani Roberts, the internationally renowned speaker, DJ, and author, joins me on the Innovation Storytellers Show to share stories about innovation in the music industry. Did you know that the song 'No Diggity’ was almost never recorded? No one wanted to sing it. And yet, when Teddy Riley believed in it and pushed forward, it became Blackstreet’s biggest hit. The lesson? If you believe in your idea, don’t let rejection stop you. It might just be your biggest breakthrough. ?? Listen Now: ?? Website: https://zurl.co/mvI2r ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa

The internationally renowned speaker, DJ, and author Amani Roberts shares many inspiring stories of innovation from the music industry on this week's episode of the Innovation Storytellers Show. Did you know that Earth, Wind & Fire turned to a famous magician to create an unforgettable, ?innovative live concert? The collaboration redefined live music experiences, but can you guess who it was? Amani Roberts reveals everything in this week's episode of the Innovation Storytellers Show. ?? Listen Now: ?? Website: https://zurl.co/jM6Vz ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa

In healthcare, every second matters—especially when it comes to stroke care. In a recent conversation, Tina Posey, CEO of HealthCarePoint, shared how her company is using big data to revolutionize clinical trials and accelerate critical care responses. Tina explained how HealthCarePoint’s platform has demonstrated remarkable results, saving up to 45 minutes from hospital arrival to revascularization for stroke patients. This time reduction can mean the difference between a full recovery and permanent disability. Additionally, the platform cuts imaging times by 42 minutes, highlighting how AI and data integration are transforming medical diagnostics and treatment coordination. The impact of such advancements is profound. By streamlining care coordination and leveraging real-time data, HealthCarePoint is setting a new standard for how healthcare providers respond to life-threatening conditions. These breakthroughs not only improve patient outcomes but also demonstrate the vital role big data plays in accelerating healthcare innovation. If reducing treatment times by minutes can save lives, imagine what broader data-driven innovations could achieve. How else do you see big data reshaping the future of healthcare? ?? Listen Now: ?? Website: https://zurl.co/Z70LP ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa

Innovation in healthcare isn’t one-size-fits-all. Different regions face different challenges, with varying regulatory environments and patient needs. In a recent conversation with Tina Posey, CEO of BlueCloudX?, we explored how they are leveraging big data to transform clinical trials on a global scale. Tina highlighted how in some regions, like Africa, clinical trials have long served as a primary care option—a stark contrast to markets like the U.S. where this approach is less common. The push for diversity, equity, and inclusion in clinical trials is finally gaining momentum, with FDA mandates opening doors for previously overlooked patient populations. But as Tina noted, inclusion is only part of the story. Gender disparities in clinical trials remain a challenge, partly because the path to rapid, accurate data is complex. Women's lives are hormonally dynamic, making cohort identification and data normalization difficult. But AI could change that. With the ability to quickly identify diverse cohorts and process vast data sets, AI could bridge the gap—enabling faster, more representative insights that improve care for all. The question is: How do we ensure that innovation benefits the widest range of people, across diverse geographies and demographics? How can big data and AI help us close the gaps in healthcare equity? Would love to hear your thoughts on how we can build a more inclusive, data-driven future for healthcare. ?? Listen Now: ?? Website: https://zurl.co/UKRI4 ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa #innovation #podcast #healthcare #technology

The pandemic shifted global attention to healthcare, sparking conversations about innovation and social good in ways we hadn’t seen before. For Tina Posey, CEO of BlueCloudX? this moment became a turning point—igniting her passion for driving meaningful change in the healthcare industry. In our recent conversation, Tina shared how HealthCarePoint is transforming clinical trials by harnessing the power of big data. The company’s platform enables pharmaceutical giants, medical device firms, and healthcare innovators to share critical competency data about the doctors and nurses involved in clinical trials. This ensures that regulatory and safety requirements are met, and that only qualified professionals are conducting these essential trials. Tina’s story highlights a crucial truth: innovation in healthcare isn’t just about breakthroughs in treatments or technology. Sometimes, it’s about building smarter systems that ensure clinical trials are safe, efficient, and accessible. By streamlining data sharing, HealthCarePoint is addressing a long-standing challenge in the industry—bridging the gaps that often slow down life-saving research. As we continue to witness the rapid evolution of healthcare, one question stands out: how can big data further accelerate innovation while ensuring patient safety and regulatory compliance? What are your thoughts on the role of data in shaping the future of clinical trials? ?? Listen Now: ?? Website: https://zurl.co/kdWk9 ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa #Innovation #Healthcare #Podcast

The battery industry wasn’t always the hotbed of innovation it is today. For Moshiel Biton, his journey into battery tech wasn’t planned—it was an evolution. From Imperial College London to founding Addionics, his story is a testament to how entrepreneurship and science can collide to create game-changing innovation. ?? In our conversation, we discuss: The shift from academic research to entrepreneurship How Tesla reshaped the perception of battery tech Why the next wave of innovation isn’t just about chemistry—it’s about scalability ?? What’s one industry you never expected to b ?? Listen Now: ?? Website: https://zurl.co/6453W ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa #Technology #Innovation #Podcast

?? Who Will Win the Battery Tech Race? No One Has a Crystal Ball… But Addionics Might. “No one has a crystal ball to predict which battery technology will win. But we provide a glimpse into the future—because we work with everyone, any chemistry, any platform, any format.” – Dr. Moshiel Biton, CEO of Addionics Investors and manufacturers hesitate to back up new battery innovations because the infrastructure is already built for existing technologies. The fear? That billions in investments could become obsolete overnight. But Addionics' drop-in solution eliminates that risk—enhancing performance without requiring new production lines. In my conversation with Dr. Moshiel Biton, we explore why battery advancements struggle to break through, how platform-based solutions could unlock mass adoption, and what it really takes to scale next-gen energy storage. ?? Listen Now: ?? Website: https://zurl.co/KJJuG ?? Apple Podcasts: zurl.co/IL53 ?? Spotify: zurl.co/w7aa ? Is the battery industry too risk-averse to embrace real change? Let’s discuss. ??